For decades, genomics led the journey from discovery to clinic — now, advances in proteomics are making a compelling case for a new leader
Partnerships with PinPoint Testing LLC, RECIPE Chemicals + Instruments GmbH and biocrates life sciences ag highlight assays and turnkey DART MS/MS solutions on the EVOQ® DART-TQ⁺
Latest product releases promise to enhance productivity
New system enables new insights into molecular interactions in label-free HTS and uHTS in drug discovery
Prolab precision pumps, autosamplers, and nano-flow to cap-LC UHPLC systems to further enhance performance and robustness of timsTOF 4D proteomics and metabolomics solutions
CCS-enabled 4D proteomics offers major capability enhancements for timsTOF Pro 2, timsTOF fleX and timsTOF SCP mass spectrometers
Used for MALDI Biotyper identification directly from positive blood cultures with short time-to-result of less than 30 minutes
The MALDI-2 source aims to increases small molecule sensitivity by one or two orders of magnitude
Introduction of new MALDI Biotyper sirius™ system with additional negative-ion mode to support MALDI research and RUO validation studies, e.g. for colistin-resistance testing
New consumables, software partners, and products for 4D proteomics announced at ASMS 2019
New Ultima 2Pplus Delivers Most Advanced and Versatile 3D Photostimulation and Full-Field Imaging for Neurobiology
Bruker’s TargetScreener HR 3.1 is proposed to enhance productivity and minimize false positives and negatives
Bruker introduces scimaX™ MRMS for novel phenomics workflows, and further enhances the timsTOF™ Pro for PASEF proteomics at ASMS
Unique trapped ion mobility spectrometry (TIMS) coupled to Bruker’s high-performance QTOF mass spectrometry enables high-resolution compound separation, significant duty cycle enhancements and studies of protein conformations, aggregation and structural isomers
The all-new rapifleX™ extends MALDI leadership in protein characterization, biologics development and QC, as well as in Mass Spectrometry Imaging (MSI)
Featuring unique PeakForce IR and IR EasyAlign technology
Label-free, MALDI-based HTS ‘in a heartbeat’ at 1 second assay time (~50,000 assays per day) with 100x less solvent cost, and faster assay development, represents a paradigm change in mass spectrometry-based HTS
Written by Jason S. Wood, Ph.D. Bruker Daltonics
